Complement component 3: A new paradigm in tuberculosis vaccine

Expert Review of Vaccines

Volumn 15, Issue 3, 2016, Pages 275-277

  De La Fuente, José ^a,b   Gortázar, Christian ^a   Juste, Ramón ^c  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

Author keywords

Complement; immunology; mycobacteria; tuberculosis; vaccine

Indexed keywords

BCG VACCINE; COMPLEMENT COMPONENT C3; INTERLEUKIN 1BETA; PATHOGEN ASSOCIATED MOLECULAR PATTERN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; BCG VACCINATION; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; INFECTION; INNATE IMMUNITY; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TRANSCRIPTOMICS; TUBERCULOSIS; WILD BOAR; ANIMAL; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; ORAL DRUG ADMINISTRATION; PIG; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; COMPLEMENT C3; DISEASE MODELS, ANIMAL; SUS SCROFA; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84959113666     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2016.1125294     Document Type: Review

References (21)

1. Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998; 6: 107-112.
2. Garrido JM, Sevilla IA, Beltrán-Beck B., et al. Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. PLoS ONE. 2011; 6: e24905.
3. Ottenhoff THM, Kaufmann SHE. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 2012; 8: e1002607.
4. Hj Z, Udwadia ZF. Advances in tuberculosis 2011-2012. Thorax. 2013; 68: 283-287.
5. Bolin CA, Whipple DL, Khanna KV., et al. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J Infect Dis. 1997; 176: 1559-1566.
6. Naranjo V, Höfle U, Vicente J., et al. Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis. FEMS Immunol Med Microbiol. 2006; 46: 298-312.
7. Naranjo V, Ayoubi P, Vicente J., et al. Characterization of selected genes upregulated in non-tuberculous European wild boar as possible correlates of resistance to Mycobacterium bovis infection. Vet Microbiol. 2006; 116: 224-231.
8. Bordet J, Gengou O. Sur lexistence de substances sensibilisatrices dans la plu-part des serum antimicrobiens. Annal Inst Pasteur. 1901; 15: 289-302.
9. Merle NS, Noe R, Halbwachs-Mecarelli L., et al. Complement system Part II: role in immunity. Front Immunol. 2015; 6: 257.
10. Beltrán-Beck B, De La Fuente J, Garrido JM., et al. Oral vaccination with heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculosis. PLoS ONE. 2014; 9 (5): e98048.
11. Carroll MV, Lack N, Sim E., et al. Multiple routes of complement activation by Mycobacterium bovis BCG. Mol Immunol. 2009; 46: 3367-3378.
12. Gonzalez SF, Lukacs-Kornek V, Kuligowski MP., et al. Complement-dependent transport of antigen into B cell follicles. J Immunol. 2010; 185: 2659-2664.
13. Meri S, Jördens M, Jarva H. Microbial complement inhibitors as vaccines. Vaccine. 2008; 26 (Suppl 8): I113-7.
14. Velasco-Velázquez MA, Barrera D, González-Arenas A., et al. Macrophage-Mycobacterium tuberculosis interactions: role of complement receptor 3. Microb Pathog. 2003; 35: 125-131.
15. Villeneuve C, Gilleron M, Maridonneau-Parini I., et al. Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process. J Lipid Res. 2005; 46: 475-483.
16. Edelson PJ, Erbs C. Biochemical and functional characteristics of the plasma membrane of macrophages from BCG-infected mice. J Immunol. 1978; 120: 1532-1536.
17. Ballesteros C, Garrido JM, Vicente J., et al. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. Vaccine. 2009; 27: 6662-6668.
18. Perez De La Lastra JM, Galindo RC, Gortázar C., et al. Expression of immunoregulatory genes in peripheral blood mononuclear cells of European wild boar immunized with BCG. Vet Microbiol. 2009; 134: 334-339.
19. Corrigendum Vet Microbiol 2009;139:209-10.
20. Bazzi S, Modjtahedi H, Mudan S., et al. Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model. Immunobiology. 2015; 220: 1293-1304.
21. Quintin J, Cheng SC, Van Der Meer JW., et al. Innate immune memory: towards a better understanding of host defense mechanisms. Curr Opin Immunol. 2014; 29: 1-7.